1. A phosphate-free pharmaceutical composition that contains at least one prostanoid FP receptor agonist and / or at least one prostamide receptor agonist, as well as citric acid salts and / or citric acid, to prevent or prevent the formation of deposits or inclusions of poorly soluble compounds calcium on the surface or inside the cornea and / or conjunctiva of the eye. 2. The phosphate-free pharmaceutical composition according to claim 1, characterized in that it prevents the formation of poorly soluble calcium compounds, calcium phosphate complexes and / or calcium phosphate compounds. A phosphate-free pharmaceutical composition that contains at least one prostanoid FP receptor agonist and / or at least one prostamide receptor agonist, as well as citric acid salts and / or citric acid to prevent calcification and / or deposits on the surface of the cornea and / or conjunctiva of the eye. 4. A phosphate-free pharmaceutical composition that contains at least one prostanoid FP receptor agonist and / or at least one prostamide receptor agonist, as well as citric acid salts and / or citric acid, for preventing corneal tape degeneration or tape keratopathy. 5. The phosphate-free pharmaceutical composition according to any one of claims 1 to 4, for a) preventing the formation of poorly soluble calcium compounds, calcium phosphate complexes and / or calcium phosphate compounds on the surface or inside the cornea and / or conjunctiva of the eye, b) prevention of calcification and / or education delayed�1. Не содержащая фосфатов фармацевтическая композиция, которая содержит по меньшей мере один агонист простаноидного FP-рецептора и/или по меньшей мере один агонист простамидного рецептора, а также соли лимонной кислоты и/или лимонную кислоту для предотвращения или профилактики образования отложений или включений слаборастворимых соединений кальция на поверхности или внутри роговицы и/или конъюнктивы глаза.2. Не содержащая фосфатов фармацевтическая композиция по п.1, характе
